These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surfactant substitution in the newborn by application of artificial surfactant. Morley CJ J Perinat Med; 1987; 15(5):469-78. PubMed ID: 3327939 [TBL] [Abstract][Full Text] [Related]
3. Dry artificial lung surfactant and its effect on very premature babies. Morley CJ; Bangham AD; Miller N; Davis JA Lancet; 1981 Jan; 1(8211):64-8. PubMed ID: 6109119 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment of very premature infants with human surfactant. Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853 [TBL] [Abstract][Full Text] [Related]
5. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [TBL] [Abstract][Full Text] [Related]
6. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed); 1987 Apr; 294(6578):991-6. PubMed ID: 2890398 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation. Morley CJ; Greenough A; Miller NG; Bangham AD; Pool J; Wood S; South M; Davis JA; Vyas H Early Hum Dev; 1988 May; 17(1):41-54. PubMed ID: 3061771 [TBL] [Abstract][Full Text] [Related]
9. Endotracheal administration of surfactant in very low birth weight infants with respiratory distress syndrome. Svenningsen N; Robertson B; Andreason B; Berggren P; Jonson B; Lindroth M Crit Care Med; 1987 Oct; 15(10):918-22. PubMed ID: 3652706 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment of premature babies with artificial surfactant (ALEC). Morley CJ Dev Pharmacol Ther; 1989; 13(2-4):182-3. PubMed ID: 2612300 [TBL] [Abstract][Full Text] [Related]
11. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study. Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103 [TBL] [Abstract][Full Text] [Related]
12. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Morley CJ Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
14. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf). Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494 [TBL] [Abstract][Full Text] [Related]
15. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109 [TBL] [Abstract][Full Text] [Related]
16. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
17. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480 [TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150 [TBL] [Abstract][Full Text] [Related]
19. Growth and development two years after artificial surfactant replacement at birth. Halliday HL; McClure G; Reid MM Early Hum Dev; 1986 Jun; 13(3):323-7. PubMed ID: 3755099 [TBL] [Abstract][Full Text] [Related]
20. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]